These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35261624)
1. Expression profile, clinical significance and biological functions of IGF2BP2 in esophageal squamous cell carcinoma. Lu F; Chen W; Jiang T; Cheng C; Wang B; Lu Z; Huang G; Qiu J; Wei W; Yang M; Huang X Exp Ther Med; 2022 Apr; 23(4):252. PubMed ID: 35261624 [TBL] [Abstract][Full Text] [Related]
2. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA. Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979 [TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA CCAT2 Promotes the Development of Esophageal Squamous Cell Carcinoma by Inhibiting miR-200b to Upregulate the IGF2BP2/TK1 Axis. Wu X; Fan Y; Liu Y; Shen B; Lu H; Ma H Front Oncol; 2021; 11():680642. PubMed ID: 34386421 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma. Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis. Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022 [TBL] [Abstract][Full Text] [Related]
6. The m6A reader IGF2BP2 promotes esophageal cell carcinoma progression by enhancing EIF4A1 translation. Li Y; Xiao Z; Wang Y; Zhang D; Chen Z Cancer Cell Int; 2024 May; 24(1):162. PubMed ID: 38724996 [TBL] [Abstract][Full Text] [Related]
7. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC). Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328 [TBL] [Abstract][Full Text] [Related]
8. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma. Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964 [TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma. Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1. Wu D; He X; Wang W; Hu X; Wang K; Wang M Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639 [TBL] [Abstract][Full Text] [Related]
11. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related]
12. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206 [TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA DLX6‑AS1 is associated with malignant progression and promotes proliferation and invasion in esophageal squamous cell carcinoma. Wang M; Li Y; Yang Y; Liu X; Zang M; Li Y; Yang K; Yang W; Zhang S Mol Med Rep; 2019 Mar; 19(3):1942-1950. PubMed ID: 30592268 [TBL] [Abstract][Full Text] [Related]
14. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042 [TBL] [Abstract][Full Text] [Related]
15. A potential biomarker of esophageal squamous cell carcinoma WTAP promotes the proliferation and migration of ESCC. Luo G; Qi Y; Lei Z; Shen X; Chen M; Du L; Wu C; Bo J; Wang S; Zhao J; Yi X Pathol Res Pract; 2022 Oct; 238():154114. PubMed ID: 36095919 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post‑transcriptional regulation of enhancer of zeste homolog 2. Xie R; Wu SN; Gao CC; Yang XZ; Wang HG; Zhang JL; Yan W; Ma TH Oncol Rep; 2017 Mar; 37(3):1682-1690. PubMed ID: 28184915 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of long non-coding RNA MYU promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells. Gu S; Qian L; Liu Y; Miao J; Shen H; Zhang S; Mao G Exp Ther Med; 2021 Jun; 21(6):644. PubMed ID: 33968175 [TBL] [Abstract][Full Text] [Related]
18. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma. Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228 [TBL] [Abstract][Full Text] [Related]
19. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma. Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer. Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]